Quinine hydrobromide manufacturers
|
| | Quinine hydrobromide Basic information |
| Product Name: | Quinine hydrobromide | | Synonyms: | 6’-methoxy-,monohydrobromide,(8-alpha,9r)-cinchonan-9-o;bromoquinine;chininhydrobromid;quinine,monohydrobromide;Quinini;(5-ethenyl-1-azabicyclo[2.2.2]octan-7-yl)-(6-methoxyquinolin-4-yl)methanol hydrobromide;(6-methoxy-4-quinolyl)-(5-vinylquinuclidin-2-yl)methanol hydrobromide;(R)-[(2S,4S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol:hydrobromide | | CAS: | 549-49-5 | | MF: | C20H25BrN2O2 | | MW: | 405.33 | | EINECS: | 208-967-2 | | Product Categories: | | | Mol File: | 549-49-5.mol |  |
| | Quinine hydrobromide Chemical Properties |
| | Quinine hydrobromide Usage And Synthesis |
| Chemical Properties | yellow prisms | | Uses | Quinidine hydrobromide is an antiarrhythmic agent. Quinidine is a potent, orally active, selective cytochrome P450db inhibitor. Quinidine hydrobromide is also a K+ channel blocker with an IC50 of 19.9 μM. Quinidine hydrobromide can be used for malaria research[1][2][3]. | | in vivo | Quinidine hydrobromide is rapidly absorbed, with peak plasma concentrations 60-90 min after an oral dose. Other salts (gluconate, polygalacturonate) are more slowly absorbed, with lower peak concentrations[2].
Quinidine hydrobromide is approximately 70-90 % bound to plasma proteins. It undergoes hepatic oxidative metabolism to form an N-oxide, a 3-hydroxy form, an O-demethyl form and 2'-quinidinone[2].
Quinidine hydrobromide inhibits metabolism of amphetamine in rats. Quinidine hydrobromide pretreatment results in a significant decrease in the excretion of p-hydroxyamphetamine at 24 and 48 h to 7.2 and 24.1% of the vehicle-control levels, respectively, accompanied by a significant increase in amphetamine excretion between 24 and 48 h to 542% of the control[3]. | | References | [1] Kehl SJ, et al. Quinidine-induced inhibition of the fast transient outward K+ current in rat melanotrophs. Br J Pharmacol. 1991 Jul;103(3):1807-13. DOI:10.1111/j.1476-5381.1991.tb09867.x
[2] Roden DM, et al. Class I antiarrhythmic agents: quinidine, procainamide and N-acetylprocainamide, disopyramide. DOI:10.1016/0163-7258(83)90012-8 |
| | Quinine hydrobromide Preparation Products And Raw materials |
|